|
|
Office Locations:
|
Center for Technology Transfer and Commercialization
1207 17th Avenue South, Suite 105
Nashville, TN 37212
Phone: 615-343-2430
Fax: 615-343-4419
| | |
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
|
|
|
|
Vanderbilt University's Center for Technology Transfer and Commercialization provides a variety of intellectual property-related services to Vanderbilt researchers, including innovation identification, protection, marketing and licensing. The Center also works with investment professionals, angel investors and experienced management teams to identify technologies that are appropriate for a commercialization strategy involving a start-up company. Vanderbilt currently maintains a portfolio of 20 active start-up companies that span a range of technologies including computerized surgical navigation, natural products for insect control, clinical information management systems, clinical diagnostics, drug discovery, radiation therapy and healthcare services. In fiscal year 2012, 40 U.S. patents were issued for Vanderbilt technologies, and 60 new licenses were granted to facilitate the transfer of scientific discovery and innovation to the commercial marketplace.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
